간독성 및 약물 유발성 간 손상 검사 시장(Hepatotoxicity & Drug-induced Liver Injury Testing Market) 2024-2031
가격문의(상세정보 참조)
구매평
Q&A
간편결제 가능구매평
Q&A
보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
간독성 및 약물 유발 간 손상 검사 시장. 간독성 및 약물 유발 간 손상 검사 시장 - 예측 (2024-2031). 2023-2028 년 동안 CAGR 6.34%로 성장한 후 2028 년까지 3 억 3,480 만 달러에 달하는 간독성 및 약물 유발 간 손상 테스트 시장 규모가 예상됩니다.
Summary
Hepatotoxicity & Drug-induced Liver Injury Testing Market. Hepatotoxicity and Drug-Induced Liver Injury Testing Market - Forecast(2024 - 2031). The hepatotoxicity & drug-induced liver injury testing market size is forecast to reach USD 334.8 million by 2028, after growing at a CAGR of 6.34% during 2023-2028
Table of Contents
1. Hepatotoxicity & Drug-induced Liver Injury Testing Market- Market Overview
1.1 Definitions and Scope
2. Hepatotoxicity & Drug-induced Liver Injury Testing Market- Executive Summary
3. Hepatotoxicity & Drug-induced Liver Injury Testing Market- Landscape
3.1.1 Market Share Analysis- Major Companies
3.1.2 Product Benchmarking- Major Companies
3.1.3 Top 5 Financials Analysis
3.1.4 Patent Analysis- Major Companies
3.1.5 Pricing Analysis
4. Hepatotoxicity & Drug-induced Liver Injury Testing Market - Startup companies Scenario Premium Premium
4.1 Top startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Product Portfolio
4.1.4 Venture Capital and Funding Scenario
5. Hepatotoxicity & Drug-induced Liver Injury Testing Market– Industry Market Entry Scenario Premium Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Successful Venture Profiles
5.4 Customer Analysis - Major companies
6. Hepatotoxicity & Drug-induced Liver Injury Testing Market- Market Forces
6.1 Market Drivers
6.2 Market Constraints
6.3 Porters five force model
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7. Hepatotoxicity & Drug-induced Liver Injury Testing Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Suppliers and Distributors Analysis
8. Hepatotoxicity & Drug-induced Liver Injury Testing Market– By Xenobiotics Type (Market Size -$ Million)
8.1 Drugs
8.2 Alcohol
8.3 Food Additives
8.4 Chlorinated Solvents
8.5 Fungal Toxins
8.6 Radioactive isotopes
8.7 Environmental toxins
8.8 Others
9. Hepatotoxicity & Drug-induced Liver Injury Testing Market– By Technology Type (Market Size -$ Million)
9.1 ELISA
9.2 Rapid Diagnostic Tests
9.3 Polymerase Chain Reaction (PCR) tests
9.4 Isothermal Nucleic Acid Amplification Technology (INAAT) tests
9.5 Imaging Tests (CT, MRI, Ultrasound etc)
9.6 Others
10. Hepatotoxicity & Drug-induced Liver Injury Testing Market– By Testing Product (Market Size -$ Million)
10.1 Testing Equipment
10.2 Assay Kits
10.3 Consumables
10.4 Software
10.5 Services
10.6 Others
11. Hepatotoxicity & Drug-induced Liver Injury Testing Market– By End User (Market Size -$ Million)
11.1 Hospitals
11.2 Diagnostic Laboratories
11.3 Blood Banks
11.4 Medical Research Labs
11.5 Pharmaceutical Companies
11.6 Others
12. Hepatotoxicity & Drug-induced Liver Injury Testing Market– By Geography (Market Size -$ Million)
12.1 North America
12.1.1 USA
12.1.2 Canada
12.1.3 Mexico
12.2 South America
12.2.1 Brazil
12.2.2 Argentina
12.2.3 Rest of SA
12.3 Europe
12.3.1 UK
12.3.2 Germany
12.3.3 France
12.3.4 Italy
12.3.5 Netherlands
12.3.6 Spain
12.3.7 Russia
12.3.8 Denmark
12.3.9 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Australia
12.4.3 Japan
12.4.4 South Korea
12.4.5 India
12.4.6 Taiwan
12.4.7 Rest of APAC
13. Hepatotoxicity & Drug-induced Liver Injury Testing Market- Entropy
13.1 New Product Launches
13.2 M&A’s, Collaborations, JVs and Partnerships
14. Hepatotoxicity & Drug-induced Liver Injury Testing Market- Industry/Segment Competition Landscape Premium
14.1 Company Benchmarking Matrix- Major Companies
14.2 Market Share at Global Level- Major companies
14.3 Market Share by Key Region- Major companies
14.4 Market Share by Key Country- Major companies
14.5 Market Share by Key Product Type- Major companies
15. Hepatotoxicity & Drug-induced Liver Injury Testing Market- Key Company List by Country Premium Premium
16. Hepatotoxicity & Drug-induced Liver Injury Testing Market Company Profiles - Product Portfolio, Financials, M&A, and Developments
16.1 Eurofins
16.2 Sigma Aldrich
16.3 Mayo Clinic
16.4 Syngene International Ltd
16.5 Visikol Inc (BICO)
16.6 Cyprotex
16.7 BioIVT
16.8 XenoTech
16.9 Hemogenix Inc
16.10 Hamilton Company
"*Financials would be provided on a best-efforts basis for private companies"
세금계산서 발행 문의
T. 070 8015 5940
보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
간독성 및 약물 유발 간 손상 검사 시장. 간독성 및 약물 유발 간 손상 검사 시장 - 예측 (2024-2031). 2023-2028 년 동안 CAGR 6.34%로 성장한 후 2028 년까지 3 억 3,480 만 달러에 달하는 간독성 및 약물 유발 간 손상 테스트 시장 규모가 예상됩니다.
Summary
Hepatotoxicity & Drug-induced Liver Injury Testing Market. Hepatotoxicity and Drug-Induced Liver Injury Testing Market - Forecast(2024 - 2031). The hepatotoxicity & drug-induced liver injury testing market size is forecast to reach USD 334.8 million by 2028, after growing at a CAGR of 6.34% during 2023-2028
Table of Contents
1. Hepatotoxicity & Drug-induced Liver Injury Testing Market- Market Overview
1.1 Definitions and Scope
2. Hepatotoxicity & Drug-induced Liver Injury Testing Market- Executive Summary
3. Hepatotoxicity & Drug-induced Liver Injury Testing Market- Landscape
3.1.1 Market Share Analysis- Major Companies
3.1.2 Product Benchmarking- Major Companies
3.1.3 Top 5 Financials Analysis
3.1.4 Patent Analysis- Major Companies
3.1.5 Pricing Analysis
4. Hepatotoxicity & Drug-induced Liver Injury Testing Market - Startup companies Scenario Premium Premium
4.1 Top startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Product Portfolio
4.1.4 Venture Capital and Funding Scenario
5. Hepatotoxicity & Drug-induced Liver Injury Testing Market– Industry Market Entry Scenario Premium Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Successful Venture Profiles
5.4 Customer Analysis - Major companies
6. Hepatotoxicity & Drug-induced Liver Injury Testing Market- Market Forces
6.1 Market Drivers
6.2 Market Constraints
6.3 Porters five force model
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7. Hepatotoxicity & Drug-induced Liver Injury Testing Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Suppliers and Distributors Analysis
8. Hepatotoxicity & Drug-induced Liver Injury Testing Market– By Xenobiotics Type (Market Size -$ Million)
8.1 Drugs
8.2 Alcohol
8.3 Food Additives
8.4 Chlorinated Solvents
8.5 Fungal Toxins
8.6 Radioactive isotopes
8.7 Environmental toxins
8.8 Others
9. Hepatotoxicity & Drug-induced Liver Injury Testing Market– By Technology Type (Market Size -$ Million)
9.1 ELISA
9.2 Rapid Diagnostic Tests
9.3 Polymerase Chain Reaction (PCR) tests
9.4 Isothermal Nucleic Acid Amplification Technology (INAAT) tests
9.5 Imaging Tests (CT, MRI, Ultrasound etc)
9.6 Others
10. Hepatotoxicity & Drug-induced Liver Injury Testing Market– By Testing Product (Market Size -$ Million)
10.1 Testing Equipment
10.2 Assay Kits
10.3 Consumables
10.4 Software
10.5 Services
10.6 Others
11. Hepatotoxicity & Drug-induced Liver Injury Testing Market– By End User (Market Size -$ Million)
11.1 Hospitals
11.2 Diagnostic Laboratories
11.3 Blood Banks
11.4 Medical Research Labs
11.5 Pharmaceutical Companies
11.6 Others
12. Hepatotoxicity & Drug-induced Liver Injury Testing Market– By Geography (Market Size -$ Million)
12.1 North America
12.1.1 USA
12.1.2 Canada
12.1.3 Mexico
12.2 South America
12.2.1 Brazil
12.2.2 Argentina
12.2.3 Rest of SA
12.3 Europe
12.3.1 UK
12.3.2 Germany
12.3.3 France
12.3.4 Italy
12.3.5 Netherlands
12.3.6 Spain
12.3.7 Russia
12.3.8 Denmark
12.3.9 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Australia
12.4.3 Japan
12.4.4 South Korea
12.4.5 India
12.4.6 Taiwan
12.4.7 Rest of APAC
13. Hepatotoxicity & Drug-induced Liver Injury Testing Market- Entropy
13.1 New Product Launches
13.2 M&A’s, Collaborations, JVs and Partnerships
14. Hepatotoxicity & Drug-induced Liver Injury Testing Market- Industry/Segment Competition Landscape Premium
14.1 Company Benchmarking Matrix- Major Companies
14.2 Market Share at Global Level- Major companies
14.3 Market Share by Key Region- Major companies
14.4 Market Share by Key Country- Major companies
14.5 Market Share by Key Product Type- Major companies
15. Hepatotoxicity & Drug-induced Liver Injury Testing Market- Key Company List by Country Premium Premium
16. Hepatotoxicity & Drug-induced Liver Injury Testing Market Company Profiles - Product Portfolio, Financials, M&A, and Developments
16.1 Eurofins
16.2 Sigma Aldrich
16.3 Mayo Clinic
16.4 Syngene International Ltd
16.5 Visikol Inc (BICO)
16.6 Cyprotex
16.7 BioIVT
16.8 XenoTech
16.9 Hemogenix Inc
16.10 Hamilton Company
"*Financials would be provided on a best-efforts basis for private companies"
